Roberta Eileen Brinton
Works at
Director, center for innovation in brai
Sources: reporter.nih.gov
Grants and prizes
U01, Transforming Alzheimer's Risk Factor Therapeutics into Precision Combination Therapies to Treat AD, U01AG095263, 2026–2031, 10 Sept 2026
P01, Perimenopause in Brain Aging and Alzheimer's Disease, P01AG026572, 2006–2031, 3 Sept 2026
T32, Translational Research in Alzheimer's Disease and related Dementias (TRADD), T32AG082631, 2023–2028, 18 Aug 2026
R01, PhytoSERM Efficacy to Prevent Menopause Associated Decline in Brain Metabolism and Cognition: A Double-Blind, Randomized, Placebo-Controlled Phase 2 Clinical Trial, R01AG075122, 2022–2027, 25 May 2026
R37, Aging and Estrogenic Control of the Bioenergetic System in Brain, R37AG053589, 2017–2027, 26 Mar 2026
R01, Allopregnanolone as Regenerative Therapeutic for Alzheimer's: Phase 2 Clinical Trial, R01AG063826, 2019–2027, 11 Jul 2025
R44, PhytoSERM for Menopausal Hot Flashes and Sustained Brain Health, R44AG078102, 2022–2026, 31 Aug 2023
Sources: reporter.nih.gov